Haide Capital and Xili Pharmaceutical Signed an Investment Agreement
In March 2012, Haide Capital Investment (Shanghai) Co., Ltd and Hebei Xinglong Xili Pharmaceutical Co., Ltd formally signed an investment agreement. After the realization of certain terms and conditions, Haide Capital will invest to Xili Pharmaceutical to become its shareholders.
Hebei Xinglong Xili Pharmaceutical Co., Ltd. is a pharmaceutical company business in production and sales of proprietary Chinese medicine products. The company has solid R&D capability in production upgrading and innovation; and has developed its own plantation for raw materials cultivation.
Haide Capital Investment (Shanghai) Co., Ltd attached great importance to this cooperation with Hebei Xinglong Xili Pharmaceutical Co., Ltd. hoping for a harmony and win-win development.
16th Floor, South Tower, Huaning International Plaza, No. 300 Xuanhua Street, Changning Direct. Shanghai 200050, P. R. China
Tel : +86 21 6167 7313
Fax : +86 21 6167 7286
haidecapital@haidecapital.com